Zhejiang Tianyu Pharmaceutical Co., Ltd.

Zhejiang Tianyu Pharmaceutical Co.,Ltd was founded in 2003. It is specialized in research, development, and manufacturing of APIs and intermediates. The company has 6 wholly-owned subsidiaries with a total employee population in excess of 4000 and occupying an area of over 470,000 square meters. Tianyu is recognized as a model high-tech enterprise in China’s Torch Program. Tianyu Pharm has been devoted to pharmaceutical intermediates and APIs of cardiovascular, antidiabetics, anti-atherosclerosis, anticoagulant and anti-asthmatic for decades. Its products are well sold in domestic and international markets, receiving high reputation from all customers.  Thorough GMP administration, excellent production equipment and methodology, state-of-the-art inspection instrumentation, and network-based data management all serve to insure the quality and reliability of our products. The company has passed USFDA certification and the GMP on-site inspections in China, Japan, Korea and other countries. 8 APIs are GMP or EIR certified in Europe or the U.S. 7 APIs have GMP certification by Chinese FDA. 10 production lines satisfy GMP requirements for synthesis and clean room. Over 50% of Tianyu’s products are employed in well-known national and international pharmaceutical companies.